Auro Laboratories Posts Strong FY26 Results: Revenue Up, Profit Doubles

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Auro Laboratories Posts Strong FY26 Results: Revenue Up, Profit Doubles
Overview

Auro Laboratories reported robust financial results for FY26, with revenue surging to ₹30.74 crore and net profit nearly doubling to ₹3.53 crore. The company also appointed a new CFO, Mr. Nitesh Bohra. Investors will be watching regulatory cost impacts.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Auro Laboratories FY26 Results Show Robust Growth, New CFO Appointed

Revenue surged to ₹30.74 crore and net profit reached ₹3.53 crore in FY 2026.
Reader Takeaway: Strong annual financial growth and new CFO appointment; monitor regulatory costs.

What just happened

Auro Laboratories Limited announced its annual financial results for FY 2026, revealing a significant increase in both revenue and net profit. The company reported revenue from operations at ₹30.74 crore, a substantial jump from ₹19.40 crore in FY 2025. Net profit also saw a considerable rise, from ₹1.84 crore in FY 2025 to ₹3.53 crore in FY 2026. Additionally, the company announced the appointment of Mr. Nitesh Bohra as its new Chief Financial Officer (CFO), effective May 29, 2026.

Why this matters

This strong financial performance indicates improved business operations and profitability for Auro Laboratories. The appointment of an experienced CFO with over 20 years in financial management signals a focus on strengthening the company's financial governance and strategic planning. The unmodified audit opinion provides assurance on the financial reporting.

The backstory

In FY 2025, Auro Laboratories had reported revenue of ₹19.40 crore and a net profit of ₹1.84 crore. The current fiscal year shows a significant acceleration in growth across key financial metrics.

What changes now

With a new CFO at the helm, the company is expected to enhance its financial management and reporting. The transition in audit appointments, including tax, internal, and cost auditors for FY 2026-27, also reflects a structured approach to governance.

Risks to watch

The company noted an incremental cost impact of ₹0.14 crore due to provisions of the new Labour Codes (Social Security Code 2020) and gratuity adjustments. While minor, this regulatory cost will be a point to monitor.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

  • Revenue FY 2026: ₹30.74 crore (vs. ₹19.40 crore in FY 2025)
  • Net Profit FY 2026: ₹3.53 crore (vs. ₹1.84 crore in FY 2025)
  • CFO Appointment: Effective May 29, 2026

What to track next

Investors should monitor the company's ability to sustain this growth trajectory, manage the incremental regulatory costs, and observe the contributions of the new CFO to the company's financial strategy.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.